UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of Raymond James (NYSE:RJF - Free Report) by 17.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,519,696 shares of the financial services provider's stock after purchasing an additional 226,633 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.74% of Raymond James worth $236,054,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Voloridge Investment Management LLC lifted its position in Raymond James by 58.1% in the fourth quarter. Voloridge Investment Management LLC now owns 348,149 shares of the financial services provider's stock valued at $54,078,000 after acquiring an additional 127,967 shares during the last quarter. Waverly Advisors LLC purchased a new stake in Raymond James in the fourth quarter valued at $2,437,000. Woodline Partners LP purchased a new stake in Raymond James in the fourth quarter valued at $1,707,000. Sovereign s Capital Management LLC purchased a new stake in Raymond James in the fourth quarter valued at $3,328,000. Finally, Tidal Investments LLC lifted its position in Raymond James by 21.1% in the fourth quarter. Tidal Investments LLC now owns 5,134 shares of the financial services provider's stock valued at $795,000 after acquiring an additional 893 shares during the last quarter. 83.83% of the stock is owned by hedge funds and other institutional investors.
Raymond James Stock Performance
Shares of Raymond James stock traded down $0.86 on Wednesday, reaching $147.18. 218,836 shares of the stock were exchanged, compared to its average volume of 1,301,376. Raymond James has a 1-year low of $104.24 and a 1-year high of $174.32. The company has a current ratio of 1.03, a quick ratio of 1.01 and a debt-to-equity ratio of 0.35. The business has a fifty day moving average price of $140.10 and a two-hundred day moving average price of $152.33. The firm has a market capitalization of $29.69 billion, a PE ratio of 14.36, a PEG ratio of 0.90 and a beta of 1.02.
Raymond James (NYSE:RJF - Get Free Report) last issued its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.42 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.44 by ($0.02). Raymond James had a return on equity of 19.71% and a net margin of 14.06%. The firm had revenue of $3.40 billion for the quarter, compared to analyst estimates of $3.46 billion. During the same quarter last year, the firm earned $2.31 earnings per share. The company's revenue was up 9.0% compared to the same quarter last year. As a group, research analysts anticipate that Raymond James will post 11.17 earnings per share for the current fiscal year.
Raymond James Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be given a dividend of $0.50 per share. The ex-dividend date is Tuesday, July 1st. This represents a $2.00 annualized dividend and a yield of 1.36%. Raymond James's payout ratio is currently 19.25%.
Insiders Place Their Bets
In other Raymond James news, insider James E. Bunn sold 3,650 shares of the company's stock in a transaction dated Monday, April 28th. The shares were sold at an average price of $136.49, for a total transaction of $498,188.50. Following the transaction, the insider now directly owns 78,227 shares in the company, valued at approximately $10,677,203.23. This represents a 4.46% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 0.54% of the stock is currently owned by company insiders.
Analyst Upgrades and Downgrades
RJF has been the topic of a number of recent research reports. Citigroup dropped their price objective on shares of Raymond James from $180.00 to $150.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 2nd. Keefe, Bruyette & Woods lifted their price objective on shares of Raymond James from $170.00 to $177.00 and gave the company a "market perform" rating in a research note on Thursday, January 30th. Cowen restated a "hold" rating on shares of Raymond James in a research note on Thursday, April 24th. Wall Street Zen lowered shares of Raymond James from a "buy" rating to a "hold" rating in a research note on Monday, February 10th. Finally, Bank of America lowered shares of Raymond James from a "buy" rating to a "neutral" rating and set a $159.00 price objective on the stock. in a research note on Wednesday, April 30th. Eleven research analysts have rated the stock with a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $153.82.
Get Our Latest Report on RJF
Raymond James Profile
(
Free Report)
Raymond James Financial, Inc, a financial holding company, through its subsidiaries, engages in the underwriting, distribution, trading, and brokerage of equity and debt securities, and the sale of mutual funds and other investment products in the United States, Canada, Europe, and internationally. The company operates through Private Client Group, Capital Markets, Asset Management, RJ Bank, and Other segments.
See Also

Before you consider Raymond James, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Raymond James wasn't on the list.
While Raymond James currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.